Loading cancer entity…
Loading cancer entity…
Clinical trials
296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (43)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | unknown | Phase 1 | 48 | Carisma Therapeutics IncINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT04551495 | Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)(ROSALINE) | unknown | Phase 2 | 65 | Jules Bordet InstituteOTHER | 2 | Dec 4, 2024 | clinicaltrials |
| NCT06357338 | Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma | unknown | — | 70 | Marwa Mahmoud HassanOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT06158217 | Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer | unknown | — | 30 | Beijing Friendship HospitalOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT05767931 | Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer | unknown | — | 60 | Peking UniversityOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05703815 | EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast | unknown | — | 40 | Sohag UniversityOTHER | 0 | Jan 31, 2023 | clinicaltrials |
| NCT01765049 | Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor(DEAR) | unknown | — | 260 | Seoul National University HospitalOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT03630913 | Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma(GANEA3) | unknown | N/A | 385 | Institut Cancerologie de l'OuestOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT03381092 | Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy | unknown | — | 348 | Peking UniversityOTHER | 1 | Nov 29, 2021 | clinicaltrials |
| NCT04004559 | MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)(RBC-02) | unknown | — | 600 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 29, 2020 | clinicaltrials |
| NCT04262518 | Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients(FIONA) | unknown | N/A | 125 | Outcomes4MeINDUSTRY | 1 | Jun 16, 2020 | clinicaltrials |
| NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | unknown | Phase 3 | 290 | RenJi HospitalOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT03109522 | Axillary Reverse Mapping (ARM) Technique(ARM) | unknown | N/A | 130 | McMaster UniversityOTHER | 1 | Feb 21, 2020 | clinicaltrials |
| NCT04021069 | Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer | unknown | — | 800 | Sunnybrook Health Sciences CentreOTHER | 1 | Jul 16, 2019 | clinicaltrials |
| NCT03566394 | Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 46 | British Columbia Cancer AgencyOTHER | 0 | Jun 25, 2018 | clinicaltrials |
| NCT03497702 | Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer(NeoChAI) | unknown | Phase 2 | 114 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 13, 2018 | clinicaltrials |
| NCT02333890 | A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer(CUBiC) | unknown | Phase 2 | 60 | Ottawa Hospital Research InstituteOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00486668 | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer | unknown | Phase 3 | 529 | NSABP Foundation IncNETWORK | 3 | Jun 6, 2016 | clinicaltrials |
| NCT01509781 | Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study | unknown | Phase 3 | 400 | National Institute of Oncology, HungaryOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer(Beva) | unknown | Phase 1 | 30 | Association Tunisienne de lutte Contre le CancerOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01597999 | Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer | unknown | Phase 4 | 60 | Mahidol UniversityOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01641406 | "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"(NACprotocol) | unknown | Phase 2 | 60 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01038258 | Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy(PETBreast) | unknown | N/A | 80 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00891280 | Dose-escalation Study of Oral CX-4945 | unknown | Phase 1 | 55 | Cylene PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01126138 | Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC) | unknown | Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 1 | May 4, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Dec 18, 2024source: clinicaltrials